Thomas Tu - Aug 16, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Signature
/s/ Shannon Trevino, attorney-in-fact for Thomas Tu
Stock symbol
NARI
Transactions as of
Aug 16, 2023
Transactions value $
-$1,647,980
Form type
4
Date filed
8/18/2023, 05:01 PM
Previous filing
Jul 5, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$806K -12.3K -3.31% $65.31 361K Aug 16, 2023 Direct F1, F2
transaction NARI Common Stock Sale -$361K -5.44K -1.51% $66.32 355K Aug 16, 2023 Direct F3
transaction NARI Common Stock Sale -$453K -6.73K -1.9% $67.31 348K Aug 16, 2023 Direct F4
transaction NARI Common Stock Sale -$27.6K -405 -0.12% $68.03 348K Aug 16, 2023 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $64.88 to $65.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $65.88 to $66.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $66.88 to $67.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $67.89 to $68.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 Includes 321 shares acquired on July 31, 2023, under the Company's Employee Stock Purchase Plan.